959 related articles for article (PubMed ID: 25503151)
21. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM
J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814
[TBL] [Abstract][Full Text] [Related]
22. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
[TBL] [Abstract][Full Text] [Related]
23. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
Fivenson DP; Hanson CA; Nickoloff BJ
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
[TBL] [Abstract][Full Text] [Related]
24. Suppressed microRNA-195-5p expression in mycosis fungoides promotes tumor cell proliferation.
Rittig AH; Johansen C; Celis P; Odum N; Litman T; Woetmann A; Lindahl LM; Iversen L
Exp Dermatol; 2021 Aug; 30(8):1141-1149. PubMed ID: 32492224
[TBL] [Abstract][Full Text] [Related]
25. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
[TBL] [Abstract][Full Text] [Related]
26. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
[TBL] [Abstract][Full Text] [Related]
27. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
Wong HK
G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-93 Targets p21 and Promotes Proliferation in Mycosis Fungoides T Cells.
Gluud M; Fredholm S; Blümel E; Willerslev-Olsen A; Buus TB; Nastasi C; Krejsgaard T; Bonefeld CM; Woetmann A; Iversen L; Litman T; Geisler C; Ødum N; Lindahl LM
Dermatology; 2021; 237(2):277-282. PubMed ID: 32335549
[TBL] [Abstract][Full Text] [Related]
29. Transformed mycosis fungoides: clinicopathological features and outcome.
Barberio E; Thomas L; Skowron F; Balme B; Dalle S
Br J Dermatol; 2007 Aug; 157(2):284-9. PubMed ID: 17573879
[TBL] [Abstract][Full Text] [Related]
30. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
31. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
32. Early-stage mycosis fungoides variants: case-based review.
Cho-Vega JH; Tschen JA; Duvic M; Vega F
Ann Diagn Pathol; 2010 Oct; 14(5):369-85. PubMed ID: 20850703
[TBL] [Abstract][Full Text] [Related]
33. Unilesional mycosis fungoides is associated with increased expression of microRNA-17~92 and T helper 1 skewing.
Moyal L; Gorovitz-Haris B; Yehezkel S; Jacob-Hirsch J; Bershtein V; Barzilai A; Rotem C; Sherman S; Amitay-Laish I; Feinmesser M; Hodak E
Br J Dermatol; 2019 May; 180(5):1123-1134. PubMed ID: 30431147
[TBL] [Abstract][Full Text] [Related]
34. Defining early mycosis fungoides: validation of a diagnostic algorithm proposed by the International Society for Cutaneous Lymphomas.
Vandergriff T; Nezafati KA; Susa J; Karai L; Sanguinetti A; Hynan LS; Ambruzs JM; Oliver DH; Pandya AG
J Cutan Pathol; 2015 May; 42(5):318-28. PubMed ID: 25721994
[TBL] [Abstract][Full Text] [Related]
35. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature.
Yost JM; Do TT; Kovalszki K; Su L; Anderson TF; Gudjonsson JE
J Am Acad Dermatol; 2009 Jul; 61(1):133-8. PubMed ID: 19539851
[TBL] [Abstract][Full Text] [Related]
36. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma.
Rübben A; Kempf W; Kadin ME; Zimmermann DR; Burg G
Exp Dermatol; 2004 Aug; 13(8):472-83. PubMed ID: 15265011
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic tools in mycosis fungoides.
Humme D; Lukowsky A; Sterry W
G Ital Dermatol Venereol; 2010 Jun; 145(3):375-84. PubMed ID: 20461045
[TBL] [Abstract][Full Text] [Related]
38. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
[TBL] [Abstract][Full Text] [Related]
39. Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.
Kopp KL; Ralfkiaer U; Nielsen BS; Gniadecki R; Woetmann A; Ødum N; Ralfkiaer E
APMIS; 2013 Nov; 121(11):1020-4. PubMed ID: 24033365
[TBL] [Abstract][Full Text] [Related]
40. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides.
Kodama K; Fink-Puches R; Massone C; Kerl H; Cerroni L
J Am Acad Dermatol; 2005 Apr; 52(4):694-8. PubMed ID: 15793526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]